Diet swap study suggests it may never be too late to modify colon cancer risk
the ONA take:
According to a new study published in the journal Nature Communications, African-Americans and Africans who swapped their usual diets for 2 weeks also exchanged their respective colon cancer risks as a result of alterations to their gut flora.
For the study, 20 African-American and 20 rural South African volunteers ate meals typical of the other group for 2 weeks.
Analyses of fecal and colon content samples showed that each group took on the other's rates of turnover of intestinal lining cells, levels of fiber fermentation, and biomarkers of inflammation and bacterial metabolic activity that are linked with colon cancer risk.
The African-American diet, which consists of more animal protein and fat, and less soluble fiber than the typical African diet is thought to increase the risk for colon cancer.
"These findings are really very good news," said principal investigator Stephen O'Keefe, M.D. professor of medicine, Division of Gastroenterology, Hepatology and Nutrition at the Pitt School of Medicine. "In just two weeks, a change in diet from a Westernized composition to a traditional African high-fiber, low-fat diet reduced these biomarkers of cancer risk indicating that it is likely never too late to modify the risk of colon cancer."
African-Americans who swapped their usual diets for 2 weeks also exchanged their respective colon cancer risks.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|